ARDSLEY ADVISORY PARTNERS LP Q3 2017 Filing

Filed November 14, 2017

Portfolio Value

$751.9M

Holdings

123

Report Date

Q3 2017

Filing Type

13F-HR

All Holdings (123 positions)

#StockSharesValue% PortfolioType
101
RGNXREGENXBIO INC
10,000$330K0.04%
102
MRKMERCK & CO INC
5,000$320K0.04%
103
SLCAU S SILICA HLDGS INC
10,000$311K0.04%
104
NUVECTRA CORP
22,095$293K0.04%
105
PEGAPEGASYSTEMS INC
5,000$288K0.04%
106
ALDXALDEYRA THERAPEUTICS INC
39,552$285K0.04%
107
AKCEA THERAPEUTICS INC
10,000$277K0.04%
108
DERMIRA INC
10,000$270K0.04%
109
CSTMCONSTELLIUM NV
25,000$256K0.03%
110
OXFORD IMMUNOTEC GLOBAL PLC
15,000$252K0.03%
111
AZURRX BIOPHARMA INC
62,500$249K0.03%
112
EAELECTRONIC ARTS INC
2,000$236K0.03%
113
BOXBOX INC
12,000$232K0.03%
114
CERSCERUS CORP
80,000$218K0.03%
115
BIOSCRIP INC
75,000$206K0.03%
116
VONAGE HLDGS CORP
25,000$204K0.03%
117
TELIGENT INC NEW
29,000$195K0.03%
118
CAPSTONE TURBINE CORP
210,000$146K0.02%
119
THERAPEUTICSMD INC
25,000$132K0.02%
120
AMDADVANCED MICRO DEVICES INC
10,000$128K0.02%
121
APOLLO ENDOSURGERY INC
18,800$88K0.01%
122
CARDIOME PHARMA CORP
36,200$77K0.01%
123
IMPRIMIS PHARMACEUTICALS INC
20,000$32K0.00%
PreviousPage 2 of 2